Evidence that heterodimers exist in the fibrinogen Matsumoto II (γ308N→K) proband and participate in fibrin fiber formation

Thrombosis Research

Volumn 107, Issue 3-4, 2002, Pages 157-162

  Okumura, Nobuo ^a   Terasawa, Fumiko ^a   Fujita, Kiyotaka ^a   Fujihara, Noriko ^b   Tozuka, Minoru ^b   Koh, Chang Sung ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chain; Co transfection; Dysfibrinogenemia; Heterodimer; Recombinant fibrinogen

Indexed keywords

DIMER; FIBRIN; FIBRINOGEN; THROMBIN; FIBRINOGEN MATSUMOTO II; FIBRINOGEN VARIANT; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CATALYST; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN BLOOD LEVEL; IMMUNOBLOTTING; MOLECULAR CLONING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CHO CELL; DIMERIZATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; METABOLISM; ULTRASTRUCTURE;

ANIMALS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRIN; FIBRINOGENS, ABNORMAL; HUMANS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; THROMBIN; TRANSFECTION;

EID: 0037104676     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00253-0     Document Type: Article

References (26)

1. Doolittle R.F., Bouma I.H., Cottrell B.A., Strong D., Watt K.W.K. The covalent structure of human fibrinogen. Bing D.H. The chemistry and physiology of the human plasma proteins. 1979;77-95 Pergamon, New York.
2. Doolittle R.F. Fibrinogen and fibrin. Sci. Am. 245:1981;92-101.
3. Hogan K.A., Lord S.T., Okumura N., Terawasa F., Galanakis D.K., Scharrer I.et al. A functional assay suggests that heterodimers exist in two C-terminal γ-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV. Thromb. Haemost. 83:2000;592-597.
4. Meh D.A., Siebenlist K.R., Galanakis D.K., Bergtrom G., Mosesson M.W. The dimeric Aα chain composition of dysfibrinogen of dysfibrinogenemic molecules with mutations at Aα16. Thromb. Res. 78:1995;531-539.
5. Shainoff J.R., Ratnoff O.D., Smejkal G.B., DiBello P.M., Welches W.R., Lill H.et al. Confirmation of Mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "Fibrinogen Amarillo" using GPRphoresis to differentiate semifibrin molecules from fibrinogen and fibrin. Thromb. Res. 101:2001;91-99.
6. 308 Asn→Lys (AAT→AAG) mutation associated with bleeding tendency. Br. J. Haematol. 94:1996;526-528.
7. Okumura N., Terasawa F., Fujita K., Tozuka M., Ota H., Katsuyama T. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, γ308K, γ308I, γ308A, and wild type. Electrophoresis. 21:2000;2309-2315.
8. Rooney M.M., Parise L.V., Lord S.T. Dissecting clot retraction and platelet aggregation. J. Biol. Chem. 271:1996;8553-8555.
9. Terasawa F., Okumura N., Kitano K., Hayashida N., Shimosaka M., Okazaki M.et al. Hypofibrinogenemia associated with a heterozygous missense mutation γ153Cys to Arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen. Blood. 94:1999;4122-4131.
10. Binnie C.G., Hettasch J.M., Strickland E., Lord S.T. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A. Biochemistry. 32:1993;107-113.
11. Okumura N., Gorkun O.V., Lord S.T. Severely impaired polymerization of recombinant fibrinogen γ-364 Asp→His, the substitution discovered in a heterozygous individual. J. Biol. Chem. 272:1997;29596-29601.
12. Takebe M., Soe G., Kohno I., Sugo T., Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen; preparation, characterization, and application to fibrinogen purification. Thromb. Haemost. 73:1995;662-667.
13. Mihalyi E. Physiological studies of bovine fibrinogen: IV. Ultraviolet absorption and its relation to the structure of the molecule. Biochemistry. 7:1968;208-223.
14. Terasawa F., Okumura N., Higuchi Y., Ishikawa S., Tozuka M., Ishida F.et al. Fibrinogen Matsumoto III: a variant with γ-275 Arg→Cys (CGC→TGC) - comparison of fibrin polymerization properties with those of Matsumoto I (γ364 Asp→His) and Matsumoto II (γ308 Asn→Lys). Thromb. Haemost. 81:1999;763-766.
15. Okumura N., Terasawa F., Tanaka H., Hirota M., Ota H., Kitano K.et al. Analysis of fibrinogen γ-chain truncations shows the C-terminus, particularly γIle387, is essential for assembly and secretion of this multichain protein. Blood. 99:2002;3654-3660.
16. Duga S., Asselta R., Santagostino E., Zeinali S.O., Simonic T., Malcovatiet al. Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood. 95:2000;1336-1341.
17. Brennan S.O., Wyatt J., Medicina D., Callea F., George P.M. Fibrinogen Brescia. Hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a γ284 Gly→Arg mutation. Am. J. Pathol. 157:2000;189-196.
18. Weisel J.W., Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations; clot structure and assembly are kinetically controlled. Biophys. J. 63:1992;111-128.
19. Miyata T., Terukina S., Matsuda M., Kasamatsu A., Takeda Y., Murakami T.et al. Fibrinogen Kawaguchi and Osaka: an amino acid substitution of Aα arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aα chains. J. Biochem. (Tokyo). 102:1987;93-101.
20. Galanakis D.K., Henschen A., Peerschke E.I.B., Kehl M. Fibrinogen Stony Brook, a heterozygous Aα16Arg→Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly. J. Clin. Invest. 84:1989;295-304.
21. 16→His): biochemical and physiologic characterization. Blood. 78:1991;1744-1752.
22. Pirkle H., Kaydewitz H., Henschen A., Theodor I. Substitution of Bβ14 arginine by cyst(e)ine in fibrinogen Seattle I. Lowe G.D.O., Douglas J.T., Forbes C.D., Henschen A. Fibrinogen 2. Biochemistry, physiology and clinical relevance. 1987;49-52 Elsevier, Amsterdam.
23. Siebenlist K.R., Prchal J.T., Mosesson M.W. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (Aα16Arg→His) containing heterodimeric molecules. Blood. 71:1988;613-618.
24. Galanakis D.K., Henschen A., Keeling M., Kehl M., Dismore R., Peerschke E.I.B. Fibrinogen Louisville: an Aα16Arg→His defect that forms no hybrid molecules in heterozygous individuals and inhibits aggregation of normal fibrin monomers. Ann. N.Y. Acad. Sci. 408:1983;644-648.
25. Huang S., Mulvihill E.R., Farrell D.H., Chung D.W., Davie E.R. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly. J. Biol. Chem. 268:1993;8919-8926.
26. Huang S., Cao Z., Chung D.W., Davie E.R. The role of βγ and αγ complexes in the assembly of human fibrinogen. J. Biol. Chem. 271:1996;27942-27947.